Expected turnaround time for a result, beginning when ARUP has received the specimen.
1-6 days
New York DOH Approval Status
Indicates test has been approved by the New York State Department of Health.
This test is New York DOH approved.
Specimen Required
Patient Preparation
Collect
Serum Separator Tube (SST).
Specimen Preparation
Separate from cells ASAP or within 2 hours of collection. Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 0.6 mL) Parallel testing is preferred and convalescent specimens must be received within 30 days from receipt of the acute specimens.
Storage/Transport Temperature
Refrigerated.
Unacceptable Conditions
Contaminated, hemolyzed, or severely lipemic specimens.
Remarks
Please mark specimens plainly as "acute" or "convalescent."
Negative - No significant level of Coccidioides IgM antibody detected.
1.0-1.4 IV
Equivocal - Questionable presence of Coccidioides IgM antibody detected. Repeat testing in 10-14 days may be helpful.
1.5 IV or greater
Positive - Presence of IgM antibody to Coccidioides detected, suggestive of current or recent infection.
Coccidioide Titer, Complement Fixation
Less than 1:2
Coccidioides immitis Abs, Precipitin
None detected.
Interpretive Data
Background information for test. May include disease information, patient result explanation, recommendations, details of testing, associated diseases, explanation of possible patient results.
Refer to report.
Compliance Category
FDA
Note
Additional information related to the test.
Negative fungal serology does not rule out the possibility of current infection. Coccidioides Antibody IgG and IgM by ELISA are used to screen for Coccidioides antibodies. If the ELISA testing is equivocal or positive for IgG and/or IgM, then Coccidioides Antibodies by Immunodiffusion, and Coccidioide Titer will be added. Additional charges apply.
The American Medical Association Current Procedural Terminology (CPT) codes published in ARUP's Laboratory Test Directory are provided for informational purposes only. The codes reflect our interpretation of CPT coding requirements based upon AMA guidelines published annually. CPT codes are provided only as guidance to assist clients with billing. ARUP strongly recommends that clients confirm CPT codes with their Medicare administrative contractor, as requirements may differ. CPT coding is the sole responsibility of the billing party. ARUP Laboratories assumes no responsibility for billing errors due to reliance on the CPT codes published.
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Chat
Feedback
